@Caronmallia @SelfLimited @stkirsch It's safe. https://t.co/eyM1vyJuis
@SelfLimited @TheJoelHunter @stkirsch A. It's a vaccine. B. It's safe. https://t.co/eyM1vyJuis C. Citation?
@jg_atma @stkirsch It's safe. https://t.co/eyM1vyJuis
@TheJoelHunter @SelfLimited @stkirsch A. The vaccine is safe https://t.co/eyM1vyJuis And for B. You weren't allowed to go to a restaurant.... you poor thing
@TheJoelHunter @NickMor78322704 @stkirsch A. Source. B. Trials are done. C. https://t.co/eyM1vyJuis
@jadonx @stkirsch It is safe. https://t.co/eyM1vyJuis
@SarahFairweat10 @stkirsch It's safe. https://t.co/eyM1vyJuis
@GirlOnYourScre3 @stkirsch https://t.co/eyM1vyJuis This data?
@Kkivik1 @stkirsch You had a choice. Nobody forced you. But choices come with consequences. They were tested and they do work. https://t.co/eyM1vyJuis The excess deaths correlate to Covid. Vaccine mandates are not unethical. They're not new either, see s
@k_b_lvi @GeneralWynne @BigGeeGee1 @BreezerGalway @DrJanKirsch Oh wow 🥴 It was released under emergency authorisation based on trial data that did not include the ARR. that is a fact. https://t.co/BNrXGQk0kD
@GeneralWynne @BigGeeGee1 @k_b_lvi @BreezerGalway @DrJanKirsch If you can find the ARR OR NNV in the originally trial data which was released, same info doctors had, I would stand corrected https://t.co/BNrXGQk0kD
@k_b_lvi @BreezerGalway @DrJanKirsch Please find the ARR… https://t.co/BNrXGQk0kD
@k_b_lvi @BreezerGalway @DrJanKirsch Please help me understand why you think they were? Because I think you are presuming they were… https://t.co/BNrXGQk0kD
@k_b_lvi @BreezerGalway @DrJanKirsch This is the information doctors and healthcare professionals were given. Can you find the ARR or NNV on here anywhere?? https://t.co/BNrXGQk0kD
RT @Heicapa1: @Haintz_Media Wie peinlich, dass die Zulassungsstudien seit 3 Jahre öffentlich einsehbar sind. 🙈 https://t.co/jBzqX0Plf7 De…
@bull_wrighter Neither are the vaccinated aside from the normal causes. Why do you feel that you have to ply us with your word vomits and ideological bollocks? It's over you #BedwettingCuck. https://t.co/emP9vWIV8Z
@KiwiFree459018 @morphnz68 Let me know when you think you can fit 200+ into 45. Its likely that your impaired judgement relies on you making assumptions, like I rely on MSM for data (I don't). It's weird that a drug is meant to kill so many, but didn't d
@MikeDonio You must be blind, deaf, and stupid then. There are countless publications supporting all of them. https://t.co/6bIA1YLT1E
@Haintz_Media Wie peinlich, dass die Zulassungsstudien seit 3 Jahre öffentlich einsehbar sind. 🙈 https://t.co/jBzqX0Plf7 Der Fremdschutz wurde erst kurz nach Zulassung speziell in Israel getestet. Das erste Ergebniss gab es Ende Februar 2021 lange vor 2
RT @BurgerLab12: @jathorpmfm @kberkopes "There has NEVER, EVER been a randomized, double-blinded, placebo-controlled clinical trial of ANY…
@ChuckCallesto All of the approved COVID vaccines have been through Phase I, II, III human clinical trails. Pfizer Phase III clinical trial data were published in Dec 2020, 95% efficacy against original covid compared to placebo vaccinated controls, good s
@KaiEvers77 @SHomburg @Sander_Lab @KlocknerMarcus Stimmt trotzdem nicht immer, aber hier ist eine: https://t.co/9GGEE12V7B
@izutama @kumagoromr こんな論文いくらでもありますやん。😳 Funding and Disclosures Supported by BioNTech and Pfizer. https://t.co/iki3o8OHK2
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
@LuddySteve @allocyttus @kelvin_morganNZ I’m neither, you need better heuristics. I can cite several placebo controlled RCT’s showing the 95% efficacy. I’ve already acknowledged that variants dramatically reduced efficacy. Can you cite atleast some credib
@ali_nicholson_ @LuddySteve @allocyttus @kelvin_morganNZ 2020 was a 10 m period vs 21, a full pandemic yr. In 2020, recording only really began in March & late in winter, there was a massive surge that spilled over to 21 + Delta variant in the summer e
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @1IDCNMI: Paper นี้ออกมาช่วง May 2021 แน่นอนว่า timing การสั่ง mRNA อาจจะทำได้ยากเพราะคิวล้น (mRNA มี full fact sheet ช่วงปลายปี2020 อั…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @1IDCNMI: Paper นี้ออกมาช่วง May 2021 แน่นอนว่า timing การสั่ง mRNA อาจจะทำได้ยากเพราะคิวล้น (mRNA มี full fact sheet ช่วงปลายปี2020 อั…
RT @1IDCNMI: Phase3 BNT162b2 (Pfizer) ตีพิมพ์ 31 Dec 2020 VE 95% ในการกันติด COVID-19 VE กันหนักกันตายเกือบ100% https://t.co/BqbcwKhaOJ
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
@jathorpmfm @kberkopes "There has NEVER, EVER been a randomized, double-blinded, placebo-controlled clinical trial of ANY VACCINE that is currently approved." https://t.co/uCsnx1kLAJ Next?
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
Phase3 BNT162b2 (Pfizer) ตีพิมพ์ 31 Dec 2020 VE 95% ในการกันติด COVID-19 VE กันหนักกันตายเกือบ100% https://t.co/BqbcwKhaOJ
Paper นี้ออกมาช่วง May 2021 แน่นอนว่า timing การสั่ง mRNA อาจจะทำได้ยากเพราะคิวล้น (mRNA มี full fact sheet ช่วงปลายปี2020 อันนี้ load มาอ่านช่วงนั้นพอดี) full paper ออก 30 Dec 2020 อันนี้ของ Pfizer ออกมาก่อน https://t.co/BqbcwKhaOJ
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
@IlTerzoElemento @longagnani @pmontevecchio @Mad_In_America un placido esempio https://t.co/6bH9Zx0VMK
ファイザーのmRNAワクチンの対各国政府販促や接種推進に大いに寄与したであろう、ワクチン有効率(新型コロナ発症の相対リスク減少)95.0%の計算ベースはこの表と思われる。 1-{(8÷18,198)÷(162÷18,325)}≓0.950 https://t.co/9N30IorTx7
@NzWillRemember @nz_factivist @ichudov Here's one, published in the New England Medical Journal in Dec 2020. https://t.co/Ca2VA5jPKo
@InfoAwOff No problem! Here you go… https://t.co/gmmjZEZLyq
発症率が0.884%(プラセボ)→0.044%(ファイザーワクチン接種)で、絶対リスクは0.84パーセンテージポイント減、相対リスクは95.0パーセント減なんてのは小学生でも理解可能で、反ワクも承知。接種開始後の展開からみて良すぎる結果だったのではと感じるのは”0.884%→0.044%”自体 https://t.co/Bq6mowT5af
@kshiro3076 @RenkaBlanche Ce qui serait bien c'est que tu utilises le DOI pour avoir l'intégrale sinon https://t.co/MrdY8Ru3FL
@NzWillRemember @nz_factivist @ichudov Sensationalized? What growing body of evidence? How about absurd claims? False? Bizarre? You must have missed the clinical trials. That was part of the vaccines testing before distribution. https://t.co/Ca2VA5jPKo
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
@Runningmansuzie @jasonwoody @DrJanKirsch @JohntheLyricist The phase three clinical trials were not inconclusive. No promise was made about any conclusive reports. Can you not read? https://t.co/Ca2VA5jPKo
@Runningmansuzie @jasonwoody @DrJanKirsch @JohntheLyricist So you believe that the vaccines fail because they don't prevent Covid? Vaccinated people got Covid from the outset, as documented in the clinical trials; far fewer than those who took the placebo
@HedgeyeEEvans @RxRegA @KenPaxtonTX @elonmusk @AlexBerenson Honestly, for most physicians, Figure 3 in the NEJM publication of the clinical trial was sufficiently convincing. I don't think Pfizer needed to do any marketing to make the case that this was an
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
@msk_ost 有効性の定義はもちろん知ってましたけど。 あなたは世界の感染症学会のレベルを疑うということですね。 あなたは、世界一の感染症専門家だったんですね。 では、反論はNEJMに投稿して下さい。 https://t.co/wfpw56HGXu
@STRAT777 @TakethatCt @GaryF56698701 @SarahCaul_ONS @stkirsch @pfizer I'm saying that they didn't do any of that. I think "suspected" was @US_FDA's terminology, not @pfizer's. It appears in FDA's briefing document for their "Vaccines and Related Biologica
@OPhreni @Quo_vadis_BRD @Sander_Lab Danke. Was genau ist nochmal ihre Argumentation gegen den Impfstoff und die Zulassungsstudie von Comirnaty?🤷♂️ "Among 10 cases of severe Covid-19 with onset after the first dose, 9 occurred in placebo recipients and 1
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
@atom_Themis @jisukewizon それ感染者数は経時的に増えていく変数ですよ。 任意の時点の人数を定数である全体で割ってたら日毎に有効率が変わるというデタラメな事になる。2つの群の罹患率が同じと仮定して、プラセボ群で162人の感染が確認された時の接種群は8人だけだったという話です。 https://t.co/LLlEYBMNG8
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
@InjectVaXUnSafe @jasonwoody @olibabba170896 @PhRMA The evidence is in the detail of the clinical trials. In the absence of data, there is no credible claim of mass deaths from the vaccines. "No deaths were considered by the investigators to be related to
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
@Macj007C @RebelleChylde @IanCopeland5 3/ Tell me why these phase 3 studies, completed before the vaccines were approved, were insufficient. Tell me what these studies lacked. What part of the analysis or methodology do you disagree with? https://t.co/onc
We're the test subjects Cause we're using all the data from "us" And some data is held back. Why? Who would want data to be held back? And why?? Non-vaxers are happy to see everything 👀 Vested interests are keen to suppress. This has all happened before. R
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
@CKellyUAP Enough of there, uncertainty & doubt using cherry-picked & incomplete sources. In multiple studies it's shown it wasn't the vaccine. https://t.co/z3F8vvwTjw https://t.co/z8xfFYlQYK
@FakeName852456 @jneas @WaitingForPerot @ClownBasket Ooohhhh, big reveal! That was also literally in their December 2020 paper that anyone could have read at any time! What a find! Fun fact: trials are never and have never been designed to measure efficacy
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
@FarmerSkeptical I am talking about the Pfizer-BioNTech COVID-19 vaccine trial that began in 2020. https://t.co/PA4PAp0h0w You can see its EU registry and ethics committee approval recorded here: https://t.co/NWGYqZ4kdI just to name one authority that
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
@MluisaSAV En el caso de Pfizer, en el estudio de seguridad y eficacia publicado en el NEJM el 31 de diciembre de 2020, la palabra placebo aparece 96 veces, pero la expresión "saline" SOLO APARECE UNA VEZ. Además, nunca dicen que sea suero fisiológico 0,9%
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
RT @PeterHotez: 5/n both mRNA vaccines were approved on their ability to prevent symptomatic infection, which they were very good at (95%)…
@ChristianTort17 @GPTurchi @Lorenzo32843904 @SophiaJiHye @CARLA5478 @LaVeritaWeb Prego: studi clinici pfizer, efficacia e sicurezza. Visto che il #novax non lo sa non vuol dire che li ha fatti Pfizer ma ospedali e centri di ricerca indipendenti. https://t.